Rene Policistico e trapianto di rene: accesso alla lista d’attesa e post trapianto: risultati della ricerca

Rossana Caldara
{"title":"Rene Policistico e trapianto di rene: accesso alla lista d’attesa e post trapianto: risultati della ricerca","authors":"Rossana Caldara","doi":"10.1177/0394936219876868","DOIUrl":null,"url":null,"abstract":"Polycystic kidney disease and kidney transplantation: access to waiting list and post-transplant Autosomal-dominant polycystic kidney disease (ADPKD) is the leading genetic cause of end-stage renal disease (ESRD) worldwide. The number of ADPKD patients who are listed for transplantation or receive a kidney transplant is continuously increasing over time. AIRP conducted a survey to investigate the ADPKD patient journey, meaning the personal experience and expectations of people regarding kidney transplantation as therapeutic option of end-stage renal failure. The survey was conducted on 381 people with ADPKD, using computer-assisted web interviewing (CAWI). The results confirm that there are problems that need to be addressed before listing an ADPKD patient for a kidney transplantation, namely the patient’s comorbidities, the complexity of pre-transplant assessments and the shortage of organs. Pre-emptive transplantation from cadaver donor is a rare event in our country but it is a valid option, especially in case of living donation. Immunosuppression is well tolerated in a high percentage of subjects, but a follow-up is necessary to monitor negative side effects. Despite these problems, the outcome of kidney transplantation is optimal in these patients. Also, the relationship between patients and Nephrologists and/or Transplant Centers is important to ensure a positive outcome.","PeriodicalId":140919,"journal":{"name":"Giornale di Techniche Nefrologiche e Dialitiche","volume":"80 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale di Techniche Nefrologiche e Dialitiche","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0394936219876868","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Polycystic kidney disease and kidney transplantation: access to waiting list and post-transplant Autosomal-dominant polycystic kidney disease (ADPKD) is the leading genetic cause of end-stage renal disease (ESRD) worldwide. The number of ADPKD patients who are listed for transplantation or receive a kidney transplant is continuously increasing over time. AIRP conducted a survey to investigate the ADPKD patient journey, meaning the personal experience and expectations of people regarding kidney transplantation as therapeutic option of end-stage renal failure. The survey was conducted on 381 people with ADPKD, using computer-assisted web interviewing (CAWI). The results confirm that there are problems that need to be addressed before listing an ADPKD patient for a kidney transplantation, namely the patient’s comorbidities, the complexity of pre-transplant assessments and the shortage of organs. Pre-emptive transplantation from cadaver donor is a rare event in our country but it is a valid option, especially in case of living donation. Immunosuppression is well tolerated in a high percentage of subjects, but a follow-up is necessary to monitor negative side effects. Despite these problems, the outcome of kidney transplantation is optimal in these patients. Also, the relationship between patients and Nephrologists and/or Transplant Centers is important to ensure a positive outcome.
多囊肾和肾移植:进入移植前和移植后名单:研究结果
多囊肾病和肾移植:常染色体显性多囊肾病(ADPKD)是世界范围内终末期肾病(ESRD)的主要遗传原因。随着时间的推移,列入移植名单或接受肾移植的ADPKD患者数量不断增加。AIRP进行了一项调查,调查了ADPKD患者的历程,这意味着人们将肾移植作为终末期肾衰竭的治疗选择的个人经历和期望。该调查采用计算机辅助网络访谈(CAWI)对381名ADPKD患者进行了调查。结果证实,在将ADPKD患者列入肾移植名单之前,有一些问题需要解决,即患者的合并症、移植前评估的复杂性和器官短缺。在我国,先取尸体的器官移植虽属罕见事件,但却是一种有效的选择,尤其是在活体捐献的情况下。免疫抑制在很大比例的受试者中耐受性良好,但有必要进行随访以监测负面副作用。尽管存在这些问题,这些患者的肾移植结果是最佳的。此外,患者与肾病学家和/或移植中心之间的关系对于确保积极的结果很重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信